STAT December 22, 2021
Helen Branswell

What do the data so far tell us about Omicron and whether it causes milder disease than previous Covid-19 variants? What can we expect to see as Omicron infections crash up against the country’s health care system? Why do Omicron waves seem to decline so quickly after scaling such heights?

We don’t know. So we asked Trevor Bedford, a computational biologist at the Fred Hutchinson Cancer Research Center in Seattle, for his thoughts.

Bedford believes that while there may be something intrinsically different about the way Omicron viruses attack human bodies, much of what is being reported in terms of mildness of cases can be explained by the fact that many people being infected have some immunity to the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID
Akiko Iwasaki: The Immunology of Covid and the Future
Novartis to acquire radiopharmaceutical firm Mariana Oncology for up to $1.75B
GLP-1 Agonists May One Day Treat Prostate Cancer
Amgen shares soar as executives outline obesity drug push
BridgeBio, Ipsen, George Medicines and more—Chutes & Ladders

Share This Article